Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy (PTSD)

What is the purpose of this trial?

The purpose of this study is to combine a single infusion of Ketamine with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.


Participation Guidelines

Ages: 21 - 70 years

Gender: Both


Yale University School of Medicine

Start Date: 03/10/2016

End Date: 11/01/2018

Last Updated: 02/22/2018

Study HIC#: 1509016530

Get Involved

For more information about this study, contact:
Charles Gordon
+1 203-937-4760
charles.gordon@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Ilan Harpaz-Rotem

Principal Investigator

Sub-Investigators